Production (Stage)
D
Pangenomic Health Inc. NARA
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 29.44% -15.94% -68.49% -55.29% -28.62%
Gross Profit -29.44% 15.94% 68.49% 55.29% 28.62%
SG&A Expenses -55.05% -70.44% -60.61% -65.74% -47.41%
Depreciation & Amortization -56.52% -31.87% -6.67% 3.37% 5.75%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -34.36% -60.01% -65.48% -66.67% -49.51%
Operating Income 34.36% 60.01% 65.48% 66.67% 49.51%
Income Before Tax -82.30% -25.68% 70.43% 70.27% 82.57%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -82.30% -25.68% 70.43% 70.27% 82.57%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -82.30% -25.68% 70.43% 70.27% 82.57%
EBIT 34.36% 60.01% 65.48% 66.67% 49.51%
EBITDA 34.22% 60.14% 65.71% 66.89% 49.68%
EPS Basic 35.70% 50.77% 88.21% 86.94% 87.42%
Normalized Basic EPS 78.08% 80.91% 75.89% 75.16% 65.74%
EPS Diluted 35.70% 50.77% 88.21% 86.94% 87.42%
Normalized Diluted EPS 78.08% 80.91% 75.89% 75.16% 65.74%
Average Basic Shares Outstanding 202.96% 143.55% 115.27% 73.12% 45.68%
Average Diluted Shares Outstanding 202.96% 143.55% 115.27% 73.12% 45.68%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --